The risk of urinary tract infections in patients with psoriasis on systemic medications in biobadaderm registry: a prospective cohort study

Abstract

Biobadaderm is a multicenter prospective cohort that was created to evaluate the safety of systemic therapy for psoriasis patients.2 Once a year, reports are created. In 2018, a signal regarding symptomatic urinary tract infection (UTI) was detected.